Woman with TTP gets new hip thanks to tailored Adzynma dosing
A woman with the rare blood disorder congenital thrombotic thrombocytopenic purpura (TTP) safely underwent hip replacement surgery while being treated with Adzynma (ADAMTS13…
Thrombotic thrombocytopenic purpura
Early plasma therapy helps woman with TTP deliver healthy baby
A 36-year-old woman in China with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby after preventive plasma therapy was started early in pregnancy,…
Steroids, IVIG key in successful management of severe immune TTP
Adults with severe immune thrombotic thrombocytopenic purpura (TTP) who are at a high risk of bleeding may be managed in a hospital’s emergency department…
Blood clots in spleen were unusual first sign in case of acquired TTP
A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP) — also known as acquired…
COVID-19 in Canada linked to clotting problems but not TTP
The number of cases of the blood disorder thrombotic thrombocytopenic purpura (TTP) did not increase during the pandemic, but COVID-19 was linked to more…
TTP in pregnancy boosts adverse maternal, fetal outcomes: Study
Pregnant women with thrombotic thrombocytopenic purpura (TTP) in the U.S. are nearly 20 times more likely to experience an adverse maternal outcome, according to…
Wayrilz recommended for approval in Europe to treat ITP
An arm of the European Medicines Agency (EMA) is recommending that Wayrilz (rilzabrutinib) be approved to treat adults with immune thrombocytopenia (ITP) who…
Switching to Adzynma slashes hospital stays in congenital TTP
Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic purpura (TTP) avoid hospital stays,…
COVID-19 triggers difficult-to-treat TTP in pregnancy for woman, 41
COVID-19 may trigger or worsen refractory, or difficult-to-treat, thrombotic thrombocytopenic purpura (TTP) during the first months of pregnancy, requiring early diagnosis and aggressive treatment…
Adzynma safely cuts relapse risk in TTP patients, new study finds
The preventive treatment Adzynma (recombinant human ADAMTS13) is safe and effective at reducing disease relapses for people with congenital thrombotic thrombocytopenic purpura (TTP), and…
